RH Valuation
Is RH * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of RH * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: RH * (MX$4750) is trading below our estimate of fair value (MX$5134.21)
Significantly Below Fair Value: RH * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for RH *?
Other financial metrics that can be useful for relative valuation.
What is RH *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$4.46b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.7x |
Enterprise Value/EBITDA | 15.9x |
PEG Ratio | 1x |
Price to Earnings Ratio vs Peers
How does RH *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 11.4x | ||
GIGANTE * Grupo Gigante S. A. B. de C. V | 14.5x | n/a | Mex$31.8b |
GSANBOR B-1 Grupo Sanborns. de | 12.8x | n/a | Mex$58.4b |
LIVEPOL C-1 El Puerto de Liverpool. de | 9.2x | 5.9% | Mex$199.3b |
GPH 1 Grupo Palacio de Hierro. de | 8.9x | n/a | Mex$16.6b |
RH * RH | 34.9x | 34.5% | Mex$4.5b |
Price-To-Earnings vs Peers: RH * is expensive based on its Price-To-Earnings Ratio (34.9x) compared to the peer average (10.9x).
Price to Earnings Ratio vs Industry
How does RH *'s PE Ratio compare vs other companies in the Global Specialty Retail Industry?
Price-To-Earnings vs Industry: RH * is expensive based on its Price-To-Earnings Ratio (34.9x) compared to the Global Specialty Retail industry average (15.1x).
Price to Earnings Ratio vs Fair Ratio
What is RH *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 34.9x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate RH *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$5,463.71 0% | 10.4% | Mex$6,986.02 | Mex$4,339.55 | n/a | 18 |
Apr ’25 | Mex$5,595.00 | Mex$5,520.04 -1.3% | 10.2% | Mex$7,041.57 | Mex$4,374.06 | n/a | 18 |
Mar ’25 | n/a | Mex$5,177.66 0% | 16.1% | Mex$7,232.91 | Mex$3,420.74 | n/a | 17 |
Feb ’25 | Mex$4,625.00 | Mex$5,137.28 +11.1% | 15.9% | Mex$7,189.00 | Mex$3,399.98 | n/a | 17 |
Jan ’25 | n/a | Mex$5,076.63 0% | 15.8% | Mex$7,238.73 | Mex$3,423.49 | n/a | 17 |
Dec ’24 | Mex$4,701.25 | Mex$5,624.88 +19.6% | 13.7% | Mex$7,358.28 | Mex$4,103.32 | n/a | 17 |
Nov ’24 | Mex$3,916.42 | Mex$6,296.82 +60.8% | 15.4% | Mex$8,048.57 | Mex$4,335.25 | n/a | 17 |
Oct ’24 | Mex$4,576.00 | Mex$5,999.19 +31.1% | 16.5% | Mex$7,717.14 | Mex$4,064.36 | n/a | 17 |
Aug ’24 | Mex$6,400.00 | Mex$4,995.90 -21.9% | 24.8% | Mex$7,166.05 | Mex$2,967.59 | n/a | 17 |
Jul ’24 | n/a | Mex$4,622.25 0% | 17.4% | Mex$6,160.32 | Mex$3,011.71 | n/a | 17 |
Jun ’24 | n/a | Mex$4,731.13 0% | 16.0% | Mex$5,837.17 | Mex$3,113.16 | n/a | 17 |
May ’24 | n/a | Mex$4,963.10 0% | 16.5% | Mex$5,950.63 | Mex$2,849.09 | n/a | 17 |
Apr ’24 | Mex$4,306.00 | Mex$5,050.51 +17.3% | 18.6% | Mex$6,938.62 | Mex$2,847.54 | Mex$5,595.00 | 17 |
Mar ’24 | n/a | Mex$6,180.02 0% | 13.0% | Mex$7,183.14 | Mex$4,011.36 | n/a | 17 |
Feb ’24 | Mex$5,769.78 | Mex$5,874.08 +1.8% | 13.1% | Mex$7,068.19 | Mex$4,052.43 | Mex$4,625.00 | 17 |
Jan ’24 | Mex$4,839.90 | Mex$6,117.37 +26.4% | 12.5% | Mex$7,446.68 | Mex$4,269.43 | n/a | 17 |
Dec ’23 | Mex$5,287.65 | Mex$6,250.01 +18.2% | 16.9% | Mex$8,128.43 | Mex$4,393.22 | Mex$4,701.25 | 17 |
Nov ’23 | n/a | Mex$6,434.17 0% | 14.9% | Mex$8,282.36 | Mex$4,851.10 | Mex$3,916.42 | 18 |
Oct ’23 | Mex$4,950.97 | Mex$6,607.52 +33.5% | 15.4% | Mex$8,386.98 | Mex$4,912.37 | Mex$4,576.00 | 18 |
Sep ’23 | Mex$5,018.00 | Mex$6,496.89 +29.5% | 20.4% | Mex$8,394.54 | Mex$4,397.14 | n/a | 18 |
Aug ’23 | Mex$5,756.00 | Mex$6,432.18 +11.7% | 20.5% | Mex$8,503.19 | Mex$4,454.05 | Mex$6,400.00 | 17 |
Jul ’23 | n/a | Mex$6,432.18 0% | 20.5% | Mex$8,503.19 | Mex$4,454.05 | n/a | 17 |
Jun ’23 | Mex$5,215.00 | Mex$9,326.71 +78.8% | 21.4% | Mex$13,792.45 | Mex$6,206.60 | n/a | 17 |
May ’23 | Mex$6,961.85 | Mex$10,258.34 +47.4% | 17.4% | Mex$13,999.44 | Mex$7,199.71 | n/a | 16 |
Apr ’23 | Mex$6,397.00 | Mex$10,565.77 +65.2% | 19.0% | Mex$14,653.58 | Mex$7,445.93 | Mex$4,306.00 | 16 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.